Tag: India’s first mRNA vaccine from Gennova gets DCGI approval

India’s first mRNA vaccine from Gennova gets DCGI approval India’s first mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19.  The vaccine will be available for adults above 18 years of age. It is a two dose vaccine to be administered intramuscularly at 28 days apart.  India, June 29, 2022: Gennova Biopharmaceuticals Ltd., a subsidiary of Emcure Pharmaceuticals Ltd., announc ed that its mRNA vaccine – GEMCOVAC™-19 - against COVID‑19 received the Emergency Use Authorization (EUA) from the office of the Drugs Controller General of India (DCGI). GEMCOVAC-19™ is the very first mRNA vaccine developed in India and only third mRNA vaccine to be approved for COVID-19 in the world. These vaccines are highly ...